Amgen (AMGN)

219.89 -1.42 (0.64%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (1/29/20 *Est.)
- Conference (11/13/2019)

Latest Headlines

UPDATE: SunTrust Starts Amgen (AMGN) at Buy November 12, 2019 4:31 AM - StreetInsider Amgen Highlights Data To Be Presented At AHA 2019 Across Cardiovascular Portfolio November 11, 2019 9:00 AM - PR NewsWire Form 4 AMGEN INC For: Nov 06 Filed by: Williams R Sanders November 7, 2019 6:22 PM - SEC Filing Form 4 AMGEN INC For: Nov 06 Filed by: SUGAR RONALD D November 7, 2019 6:21 PM - SEC Filing Amgen To Present At The 28th Annual Credit Suisse Healthcare Conference November 7, 2019 5:01 PM - PR NewsWire Form 4 AMGEN INC For: Nov 01 Filed by: Johnston Lori A November 5, 2019 6:56 PM - SEC Filing Form 4 AMGEN INC For: Nov 01 Filed by: Graham Jonathan P November 5, 2019 6:54 PM - SEC Filing Form 4 AMGEN INC For: Nov 02 Filed by: Gordon Murdo November 5, 2019 6:50 PM - SEC Filing Form 4 AMGEN INC For: Nov 01 Filed by: Kullman Ellen Jamison November 5, 2019 6:44 PM - SEC Filing Form 4 AMGEN INC For: Nov 01 Filed by: HOLLEY CHARLES M November 5, 2019 6:42 PM - SEC Filing UPDATE: Cantor Fitzgerald Upgrades Amgen (AMGN) to Overweight November 5, 2019 6:03 AM - StreetInsider BeiGene, Ltd. (BGNE) PT Raised to $210 at Maxim Group November 4, 2019 7:53 AM - StreetInsider Pre-Open Movers 11/01: (BGNE) (CRC) (LOCO) Higher; (ANET) (CASA) (PINS) Lower (more...) November 1, 2019 9:28 AM - StreetInsider After-Hours Movers 10/31: (BGNE) (LOCO) (QRVO) Higher; (ANET) (CASA) (PINS) Lower (more...) October 31, 2019 5:25 PM - StreetInsider Form 8-K AMGEN INC For: Oct 31 October 31, 2019 5:06 PM - SEC Filing Amgen (AMGN) will acquire 20.5% stake in BeiGene (BGNE) for approximately $2.7 billion in cash October 31, 2019 4:01 PM - StreetInsider BeiGene Announces Global Strategic Oncology Collaboration with Amgen October 31, 2019 4:00 PM - Globe NewsWire Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China October 31, 2019 4:00 PM - PR NewsWire The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature October 30, 2019 6:00 PM - PR NewsWire Amgen (AMGN) PT Raised to $205 at SVB Leerink October 30, 2019 9:33 AM - StreetInsider Amgen (AMGN) PT Raised to $253 at Cowen October 30, 2019 7:45 AM - StreetInsider Amgen (AMGN) PT Raised to $225 at Credit Suisse October 30, 2019 7:14 AM - StreetInsider Amgen (AMGN) PT Raised to $245 at Citi October 30, 2019 6:14 AM - StreetInsider Form 10-Q AMGEN INC For: Sep 30 October 30, 2019 6:09 AM - SEC Filing Form 8-K AMGEN INC For: Oct 29 October 29, 2019 5:09 PM - SEC Filing Amgen (AMGN) Tops Q3 EPS by 13c, Revenues Beat; Raises FY19 EPS/Revenue Guidance October 29, 2019 4:03 PM - StreetInsider Amgen Reports Third Quarter 2019 Financial Results October 29, 2019 4:01 PM - PR NewsWire Amgen (AMGN) Pushes to Session Highs October 29, 2019 1:10 PM - StreetInsider Mizuho Securities Reiterates Neutral Rating on Amgen (AMGN) October 29, 2019 7:23 AM - StreetInsider Amgen Announces Webcast of 2019 Third Quarter Financial Results October 24, 2019 4:00 PM - PR NewsWire Form CT ORDER AMGEN INC October 24, 2019 9:06 AM - SEC Filing Amgen (AMGN) to Make Repatha Available Exclusively at Lower List Price Option October 24, 2019 9:01 AM - StreetInsider Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020 October 24, 2019 9:00 AM - PR NewsWire Amgen Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Corporation October 23, 2019 4:00 PM - PR NewsWire Amgen (AMGN) CFO David Meline to Retire October 23, 2019 6:19 AM - StreetInsider Form 8-K AMGEN INC For: Oct 22 October 23, 2019 6:07 AM - SEC Filing David Meline, Amgen's Chief Financial Officer, To Retire October 22, 2019 7:22 PM - PR NewsWire U.S. charges six investment bankers over insider trading scheme October 22, 2019 5:54 PM - StreetInsider Amgen (AMGN) Declares $1.45 Quarterly Dividend; 2.8% Yield October 22, 2019 4:00 PM - StreetInsider Amgen Announces 2019 Fourth Quarter Dividend October 22, 2019 4:00 PM - PR NewsWire Form 8-K AMGEN INC For: Oct 17 October 18, 2019 5:10 PM - SEC Filing Amgen (AMGN) Announces Nplate Now Approved For Earlier Use in Adults With Immune Thrombocytopenia October 18, 2019 9:01 AM - StreetInsider Nplate® (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia October 18, 2019 9:00 AM - PR NewsWire Amgen (AMGN) Reports EVENITY (Romosozumab) Granted Positive CHMP Opinion for Treatment Of Severe Osteoporosis in Postmenopausal Women October 18, 2019 5:55 AM - StreetInsider EVENITY® (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture October 18, 2019 1:00 AM - PR NewsWire UPDATE: BofA/Merrill Lynch Reinstates Amgen (AMGN) at Neutral October 16, 2019 4:29 PM - StreetInsider Sports Anchor And Multiple Myeloma Patient Rod Gilmore Joins Amgen's Myeloma MVP™ Team October 15, 2019 9:00 AM - PR NewsWire Bernstein Reinstates Amgen (AMGN) at Outperform October 14, 2019 6:59 AM - StreetInsider Amgen Foundation Launches Amgen Biotech Experience In Pittsburgh October 9, 2019 9:05 AM - PR NewsWire Form 4 AMGEN INC For: Oct 02 Filed by: SUGAR RONALD D October 3, 2019 5:07 PM - SEC Filing Pre-Open 09/30: (DOVA) (BBBY) (SGEN) Higher (IMMU) (CALM) (MRTX) Lower (more...) September 30, 2019 9:26 AM - StreetInsider Amgen's (AMGN) ESMO Data Highlights AMG-510 as a Top Pipeline Program - Cantor Fitzgerald September 30, 2019 8:39 AM - StreetInsider Amgen (AMGN) Reiterated Outperform at BMO Capital After Phase 1 Data at ESMO September 30, 2019 8:31 AM - StreetInsider Goldman Sachs Reiterates Buy Rating on Amgen (AMGN) After ESMO Data September 30, 2019 8:29 AM - StreetInsider Amgen's (AMGN) AMG 510 Achieves an ~8% ORR in CRC - RBC Capital September 30, 2019 8:26 AM - StreetInsider Amgen (AMGN) ESMO AMG510 Presentation Shows Promise - SVB Leerink September 30, 2019 8:19 AM - StreetInsider Mirati Therapeutics (MRTX) Weakness Tied to Amgen's (AMGN) AMG 510 Data September 30, 2019 7:48 AM - StreetInsider Amgen (AMGN) Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO September 30, 2019 7:23 AM - StreetInsider Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019 September 28, 2019 1:00 AM - PR NewsWire Heart Attack Survivors Are Taking Steps To Reduce Their Cardiovascular Risk. But Are They The Right Ones? September 26, 2019 9:02 AM - PR NewsWire Amgen To Webcast Investor Call At ESMO 2019 September 25, 2019 4:00 PM - PR NewsWire Amgen (AMGN) Reports Positive Results from Two Phase 3 BLINCYTO (blinatumomab) Studies Pediatric Patients with Relasped ALL September 24, 2019 4:02 PM - StreetInsider Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (blinatumomab) Studies In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia September 24, 2019 4:00 PM - PR NewsWire Amgen Showcases New Data From Oncology Pipeline And Portfolio At ESMO 2019 September 17, 2019 4:00 PM - PR NewsWire S&P 500 Q2 Stock Buybacks Fall 20.1% Sequentially, 13.7% YoY September 16, 2019 11:34 AM - StreetInsider S&P 500 buybacks decline significantly in Q2 2019; expenditures still remain higher than the pre-2018 levels September 16, 2019 11:30 AM - PR NewsWire Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference September 13, 2019 4:00 PM - PR NewsWire Amgen (AMGN) Announces Phase 3 CANDOR Study Combining KYPROLIS And DARZALEX Meets Primary Endpoint of PFS September 13, 2019 9:02 AM - StreetInsider Amgen Announces Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) Meets Primary Endpoint Of Progression-Free Survival September 13, 2019 9:00 AM - PR NewsWire SVBLeerink Negative on Amgen (AMGN) September 12, 2019 3:08 PM - StreetInsider Amgen (AMGN) Announces New Data from KYPROLIS (carfilzomib) & Oncology Pipeline at IMW 2019 Meetings September 12, 2019 9:04 AM - StreetInsider Amgen Highlights New Data From KYPROLIS® (carfilzomib) And Oncology Pipeline At IMW 2019 September 12, 2019 9:00 AM - PR NewsWire deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants September 11, 2019 11:50 AM - PR NewsWire Pre-Open Movers 09/09: (ACAD) (CYOU) (FNMA) Higher; (NTRP) (FRED) (PAYS) Lower (more...) September 9, 2019 9:27 AM - StreetInsider Baird Reiterates Neutral Rating on Amgen (AMGN) September 9, 2019 8:26 AM - StreetInsider Amgen (AMGN) World Lung KRAS Update Supports Rapid Filing Strategy - Oppenheimer September 9, 2019 8:03 AM - StreetInsider Amgen (AMGN) Phase 1 Data Confirms Expected Response Rate - BMO Capital September 9, 2019 7:59 AM - StreetInsider Amgen (AMGN) Thoughts After Ph1 Data - Mizuho September 9, 2019 7:53 AM - StreetInsider Amgen (AMGN): Durability Will Be A Key 2020 Question - Cantor Fitzgerald September 9, 2019 7:45 AM - StreetInsider Wall Street ends flat amid rate hopes, tech declines September 9, 2019 7:25 AM - StreetInsider Amgen (AMGN) PT Raised to $243 at Goldman Sachs After AMG 510 Lung Cancer Response Rate Data Appears In-Line September 9, 2019 7:20 AM - StreetInsider Amgen (AMGN) 510 Update at WCLC Consistent with Filing in 2020 - Morgan Stanley September 9, 2019 7:09 AM - StreetInsider Cantor Fitzgerald Reiterates Neutral Rating on Amgen (AMGN) September 9, 2019 7:03 AM - StreetInsider Amgen (AMGN) Announces New Data Evaluating Novel Investigational KRAS(G12C) Inhibitor in Larger Patient Group at WCLC September 9, 2019 6:20 AM - StreetInsider Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Larger Patient Group At WCLC 2019 September 8, 2019 3:45 AM - PR NewsWire Amgen To Present At The Morgan Stanley Global Healthcare Conference September 5, 2019 4:00 PM - PR NewsWire Amgen (AMGN) PT Raised to $230 at Cantor Fitzgerald Ahead of World Lung September 5, 2019 6:47 AM - StreetInsider Form 4 AMGEN INC For: Sep 04 Filed by: SUGAR RONALD D September 4, 2019 6:09 PM - SEC Filing Form 4 AMGEN INC For: Aug 30 Filed by: Patton Cynthia M September 4, 2019 6:07 PM - SEC Filing Amgen To Webcast Investor Call At IASLC 2019 World Conference on Lung Cancer September 4, 2019 4:00 PM - PR NewsWire Pre-Open 08/30: (SEAC) (AMBA) (MSGN) Higher (ULTA) (AOBC) (ALXN) Lower (more...) August 30, 2019 9:19 AM - StreetInsider Alexion Pharma (ALXN) Soliris patents get review on Amgen (AMGN) challenge at patent office - Bloomberg August 30, 2019 8:49 AM - StreetInsider Amgen (AMGN) patent on blockbuster Repatha drug invalid, judge rules - Bloomberg (REGN) August 28, 2019 3:05 PM - StreetInsider Amgen (AMGN) call put ratio 1 call to 1.3 puts August 28, 2019 3:04 PM - StreetInsider New Amgen Data To Be Presented At ESC Congress 2019 Highlight Additional Evidence For Repatha® (Evolocumab) Effectiveness In Cardiovascular Disease Across Multiple Patient Groups August 28, 2019 9:00 AM - PR NewsWire Amgen (AMGN) PT Raised to $189 at SVB Leerink August 28, 2019 6:58 AM - StreetInsider Amgen (AMGn) PT Raised to $206 at RBC Capital August 27, 2019 6:23 AM - StreetInsider Amgen (AMGN) PT Raised to $240 at BMO Capital; Otezla Deal 'Makes Strategic Sense' August 26, 2019 3:59 PM - StreetInsider Amgen (AMGN) PT Raised to $218 at Piper Jaffray August 26, 2019 12:30 PM - StreetInsider Amgen (AMGN) Otezla Deal 'Highly Accretive' - Cowen August 26, 2019 11:44 AM - StreetInsider Form 8-K AMGEN INC For: Aug 26 August 26, 2019 10:32 AM - SEC Filing Pre-Open Movers 08/26: (FBIO) (MDCO) (PBI) Higher (ALXN) (CREE) (AMGN) Lower (more...) August 26, 2019 9:28 AM - StreetInsider Surprise... Amgen (AMGN) Didn't Buy Alexion Pharma (ALXN) August 26, 2019 9:15 AM - StreetInsider Wall Street bounces as trade temperature cools August 26, 2019 8:00 AM - StreetInsider Bristol-Myers Squibb (BMY) Gains 5% on Celgene's Deal to Sell Otezla to Amgen August 26, 2019 6:50 AM - StreetInsider Amgen (AMGN) to Acquire Otezla from Celgene (CELG) for $13.4B August 26, 2019 6:32 AM - StreetInsider Amgen To Acquire Otezla® For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits August 26, 2019 6:30 AM - PR NewsWire Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion August 26, 2019 6:30 AM - BizWire Alexion Pharma (ALXN) Takeover By Amgen (AMGN) 'Highly Unlikely' - Cowen August 23, 2019 6:42 AM - StreetInsider Amgen (AMGN) and Alexion (ALXN) Combo Isn't a Crazy Idea - Mizuho August 23, 2019 6:37 AM - StreetInsider Alexion (ALXN) Takeover by Amgen (AMGN) 'Not Likely' - Sources August 22, 2019 3:48 PM - StreetInsider Piper Jaffray Reiterates Overweight Rating on Amgen (AMGN) August 22, 2019 12:45 PM - StreetInsider Amgen (AMGN)/Alexion Pharma (NASDAQ: ALXN) engaged in rather protracted and nasty legal fight over biosimilar Soliris in Europe - Adam Feurstein August 22, 2019 12:00 PM - StreetInsider Alexion Pharma (ALXN)/Amgen (AMGN) Merger 'Not a Crazy Thought' - Mizuho August 22, 2019 10:57 AM - StreetInsider Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan® (Rituximab) August 22, 2019 9:00 AM - PR NewsWire Amgen (AMGN) PT Raised to $235 at Jefferies August 22, 2019 5:13 AM - StreetInsider Alexion Pharma (ALXN) Ticks Higher on Renewed Chatter August 21, 2019 1:54 PM - StreetInsider Amgen (AMGN) PT Raised to $192 at RBC Capital on Increased Enbrel Sales August 21, 2019 6:35 AM - StreetInsider Amgen (AMGN) PT Raised to $192 at RBC Capital August 21, 2019 6:28 AM - StreetInsider Active options: BAC PCG BIDU AMZN NFLX T MU HD TEVA BYND X TGT August 19, 2019 3:36 PM - StreetInsider Mizuho Securities Downgrades Amgen (AMGN) to Neutral August 19, 2019 6:21 AM - StreetInsider Amgen (AMGN) PT Raised to $225 at Credit Suisse August 16, 2019 8:51 AM - StreetInsider Full Article List